From November 21 to 22, 2025, the “2025 Palliative Care Professional Committee Conference and NanoKnife Ablation Clinical Application Symposium,” hosted by the Sichuan Medical Doctor Association and organized by its Palliative Care Professional Committee, will be held grandly at Chengdu Longemont Hotel. As one of the important co-organizers, Chengdu Huanya Hospital is deeply involved in this academic event. Professor Liao Zhengyin, our hospital's chief expert in interventional therapy, and team experts Director Zhou Liang, Director Luo Jiamin, and Director Zhang Junxi will deliver keynote reports to share the “Huanya experience” of NanoKnife technology in pancreatic cancer treatment.
With the theme “Uniting Efforts to Explore the Path of Palliative Care: Lighting Hope for Life and Safeguarding Peace for Patients,” this conference brings together leading experts and scholars in palliative care and interventional oncology from across the province.
Professor Xiao Yueyong, First Medical Center of Chinese PLA General Hospital
Figure 2: Professor Huang Xuequan, Southwest Hospital, Army Medical University
Figure 3: Dr. Wei Yingtian, First Medical Center of Chinese PLA General Hospital
Figure 4: Director Chen Shengkai, Chongqing People's Hospital
Figure 5: Professor Xu Xinyu, Tianjin Medical University
Opening remarks by Leader Wang Xianmin of the Sichuan Medical Doctor Association
Director Hua Chengge of West China Hospital of Stomatology, Sichuan University, shared “Prevention and Treatment of Medication-Related Osteomyelitis.”
Director Yi Cheng of West China Hospital, Sichuan University, shared “The Therapeutic Effects of Muscle Balance Isotonic Training on Subhealth and Chronic Diseases.”
Director Xie Ke of Sichuan Provincial People's Hospital shared “Viewing Standardized Cancer Pain Management in China Through Clinical Practice Issues.”
Our chief expert, Professor Liao Zhengyin, delivered two major reports at the conference: “Exploration and Reflections on NanoKnife Treatment” and “Analysis of the Application and Efficacy of NanoKnife Technology in the Treatment of Biliary and Pancreatic Tumors.”
Professor Liao Zhengyin shared “Exploration and Reflections on NanoKnife Treatment” and “Analysis of the Application and Efficacy of NanoKnife Technology in the Treatment of Biliary and Pancreatic Tumors.”
Our expert Director Zhou Liang presented “Huanya Experience in NanoKnife Ablation: Clinical Application of NanoKnife in the Treatment of Pancreatic Cancer.” Director Luo Jiamin presented two important topics: “Combination Upgrade, More Vitality: LEAP-012 Helps Patients with Unresectable Non-Metastatic HCC Achieve Longer Survival” and “Interventional Treatment of Head and Neck Tumors.” Director Zhang Wendong delivered a keynote speech on “Approaches to Diagnosis and Treatment of Pulmonary Nodules.”
Director Zhou Liang, Chengdu Huanya Hospital
Director Luo Jiamin, Chengdu Huanya Hospital
Director Zhang Wendong, Chengdu Huanya Hospital
Our experts systematically introduced a series of clinical application achievements and surgical practical experience gained by our hospital in the cutting-edge field of irreversible electroporation technology for tumor treatment. This was not only a concentrated demonstration of our hospital's technical strength, but also a strong response to the conference theme — using precise, minimally invasive advanced technology to effectively control tumors while greatly protecting organ function, reducing treatment side effects, and truly improving patients' quality of life and dignity.
Technology-Led Development Driving Professional Growth
Chengdu Huanya Hospital has always adhered to driving discipline development with cutting-edge technologies. As a key development direction of our Interventional Oncology Department, NanoKnife ablation technology has been successfully applied to many patients with complex hepatobiliary and pancreatic tumors, achieving significant clinical results. Sharing the “Huanya experience” this time aims to work with peers in the field to jointly promote standardized application and innovative exploration of minimally invasive interventional technologies such as NanoKnife within the province, benefiting more patients.
Upholding Benevolence and Fulfilling Social Responsibility
Actively participating in technological innovation and co-hosting high-level academic conferences of this kind is an important reflection of Chengdu Huanya Hospital's fulfillment of social responsibility. The hospital has always upheld the philosophy that “medicine has limits, but care has no end,” integrating palliative care into the full-course management of tumor patients. We deeply understand that a doctor's responsibility is not only to treat disease, but also to care for patients. By supporting such academic platforms, we hope to promote the overall improvement of palliative care in the region, advance the transformation of the medical model from disease treatment to humanistic care, and contribute “Huanya strength” to the building of “Healthy Sichuan.”
Through this conference, Chengdu Huanya Hospital once again clarified its direction as a socially responsible medical institution: to keep climbing to new heights in technology, to deliver warmth in service, and to work tirelessly toward the vision of “lighting hope for life and safeguarding peace for patients.”
